Licofelone significantly inhibited the development of oral cancer in rats. Compound inhibited both the COX and LOX pathways. Potential treatment produced no observable side effects. ANAHEIM, Calif. — The compound licofelone inhibited oral cancer...
Filed under: Press Releases, Research, Conference, Cancer, Media Materials, AACR, cancer prevention, American Association for Cancer Research, prevention, press conference, Frontiers in Cancer Prevention Research, oral cancer, Dr. David McCormick, licofelone